Target intelligence / Profile preview

Cockayne syndrome A protein (CSA)

Target
CSA
Molecular classification
DNA repair protein, WD repeat protein, E3 ubiquitin ligase complex component
01

Overview

Cockayne syndrome A protein (CSA) is encoded by the ERCC8 gene located on chromosome 5q12.1. The CSA protein is a DNA repair factor that functions as a substrate-recognition component of the DCX (DDB1-CUL4-X-box) E3 ubiquitin–protein ligase complex. Its main role is in transcription-coupled nucleotide excision repair (TC-NER), where it helps remove RNA polymerase II-blocking DNA lesions from actively transcribed genes. Mutations in the ERCC8 gene impair this DNA repair process, leading to Cockayne syndrome type A—a rare, fatal, autosomal recessive neurodegenerative disorder marked by growth failure, developmental delays, photosensitivity, and premature aging. ERCC8 mutations are not associated with increased cancer risk.

Other names
ERCC8CSACockayne syndrome A proteinCS-A
02

Mechanism of action

Not applicable for drug targeting, as this molecule is not currently a therapeutic target; its role is intrinsic in DNA repair

03

Biological functions

DNA repair (specifically transcription-coupled nucleotide excision repair, TC-NER)
04

Disease associations

Neurodegenerative disease (Cockayne syndrome)PhotosensitivityPremature aging syndromes
05

Safety considerations

Individuals with Cockayne syndrome (due to ERCC8 mutations) have extreme sensitivity to UV light and serious adverse reactions to metronidazole, which can cause life-threatening liver failure
06

Interacting drugs

Metronidazole
07

Biomarkers

Genetic testing for ERCC8 mutations is used as a diagnostic biomarker for Cockayne syndrome

Beyond the preview

Go deeper on Cockayne syndrome A protein (CSA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cockayne syndrome A protein (CSA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call